NASDAQ

NeuroSense Therapeutics Ltd. - Warrant (NRSNW)

511 Thanks from members

NeuroSense Therapeutics Ltd. (NRSNW) faces severe distress, highlighted by going concern doubts, low cash reserves, and Nasdaq compliance deadlines.

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →